Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study
Key facts
- Who runs it
- Duke University
- Where
- Durham, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 59 people enrolled
- Started
- 14 May 2024
- Ended
- 8 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- High Frequency Repetitive Transcranial Magnetic Stimulation (HF rTMS)
- Sham Repetitive Transcranial Magnetic Stimulation (sham- rTMS)
- Cognitive Restructuring
- Record updated
- 17 July 2026
Who can take part
- Age
- 18 years to 55 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- 18-55
- verbal agreement to maintain dose of prescribed psychotropic medication (if any) and/or psychotherapy (if any) constant throughout the study, provided they are stable on it for the past 4 weeks (except exclusion medication and except if there is a medical emergency requiring changes in medication)
- DMQ Impairment score >= 14
Who cannot take part
- use of investigational drug or devices within 4 weeks of screening
- started/changed psychotropic medications or started psychotherapy in the prior 4 weeks, or plans to change medication or stop psychotherapy during the study
- current or past history of mania or psychosis; current hypomania
- not medically cleared for TMS or fMRI (such as taking medications known to reduce the seizure threshold such as Lithium, Clozaril, stimulants including the ADHD medications (e.g. Ritalin, Adderall), Wellbutrin/Buproprion, Provigil (Modafinil), Aminophylline, and Theophylline)
- DMQ Impairment score < 14
- moderate/severe current alcohol or substance use disorder, or past severe alcohol use disorder
- current uncontrolled anorexia or other condition requiring hospitalization
- conditions associated with increased intracranial pressure, space occupying brain lesion, transient ischemic attack, cerebral aneurysm, dementia, Parkinson's or Huntington's disease, multiple sclerosis
- younger than 18 and older than 55
- verbal IQ< 90 as per the NART
- pregnant
- high risk for suicide (defined as having attempted suicide in past 6 months; suicide attempt within the past 10 years with current ideation with plan or preferred method available)
- unable to read, blind, or deaf, or unwilling to give consent
- cannot come to Duke for the in-person study visits
Where in United States
- Duke University Medical CenterDurham, United States
About the trial
What the trial wants to find out
Misophonia, the inability to tolerate certain repetitive distressing sounds that are common, is gaining, recognition as an impairing condition. It is not a well-understood condition and there are no known treatments. The purpose of this study is to test a new misophonia intervention that uses emotion regulation strategies and different types of brain stimulation on misophonic distress. This study will examine changes in brain activity during presentation and regulation of misophonic versus distressing sounds. The study team plans to alter activity in a key area of the brain responsible for emotion regulation circuitry over 4 sessions with the goal to test if this intervention helps misophonic distress.
Read full original descriptionShow less
Sixty adult participants with moderate to severe misophonia will be recruited and taught an emotion regulation skill and randomly assigned to receive one of two types of repetitive transcranial magnetic stimulation (rTMS). The study includes 9-10 visits: the remote screening visit(s), the initial MRI, the four neurostimulation sessions, the follow-up MRI, and two additional remote 1- and 3-month follow-up visits.
The 2 groups in the trial
- Cognitive Restructuring + High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS)Treatment being tested
30 eligible participants will receive training in Cognitive Restructuring (CR). These participants will use CR while being exposed to misophonic trigger sounds and also receiving high frequency rTMS over their personalized right dorsal lateral prefrontal cortex (dlPFC) target. These participants will partake in short term and long term follow-up testing.
Treatment: High Frequency Repetitive Transcranial Magnetic Stimulation (HF rTMS) and Cognitive Restructuring
- Cognitive Restructuring + Shame Repetitive Transcranial Magnetic Stimulation (rTMS)Existing treatment, for comparison
30 eligible participants will receive training in Cognitive Restructuring (CR). These participants will use CR while being exposed to misophonic trigger sounds and also receiving placebo rTMS over their personalized right dorsal lateral prefrontal cortex (dlPFC) target. These participants will partake in short term and long term follow-up testing.
Treatment: Sham Repetitive Transcranial Magnetic Stimulation (sham- rTMS) and Cognitive Restructuring
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 17 July 2026